| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Oramed Pharmaceuticals Inc. (ORMP) have been net sellers, shedding 50,000 shares worth roughly $226K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.14M | $17.10M | - | |
| Other | 1.55M | $6.40M | - | |
| COO | 1.33M | $5.49M | - | |
| CFO | 861.1K | $3.56M | - | |
| Dir | 168.0K | $693.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2017 | Miriam Kidron | Chief Scientific Officer | Sell | 89,636 | $8.50 | $761,906.00 | -54.4% | |
| Aug 2, 2017 | Xiaopeng Li | Director | Buy | 89,636 | $8.50 | $761,906.00 | +76.8% | |
| Apr 19, 2017 | Miriam Kidron | Chief Scientific Officer | Sell | 52,814 | $6.33 | $334,312.62 | -37.1% | |
| Apr 19, 2017 | Xiaopeng Li | Director | Buy | 52,814 | $6.33 | $334,312.62 | +82.7% | |
| May 12, 2016 | Nadav Kidron67 | President and CEO | Buy | 1,000 | $6.95 | $6,953.00 | +0.1% | |
| Mar 10, 2016 | Harold Jacob | Director | Sell | 8,500 | $6.45 | $54,842.00 | -34.1% | |
| Dec 30, 2015 | Miriam Kidron | Chief Technology Officer | Sell | 50,000 | $8.90 | $444,799.70 | -26.0% | |
| Dec 9, 2015 | Michael Berelowitz | Director | Sell | 700 | $9.44 | $6,608.00 | -3.0% | |
| Dec 8, 2015 | Michael Berelowitz | Director | Sell | 1,300 | $8.70 | $11,310.00 | -5.2% | |
| May 12, 2015 | Nadav Kidron67 | President and CEO | Buy | 600 | $6.60 | $3,962.00 | - |